MolVerity AI helps discovery organizations screen, prioritize and de-risk candidate molecules before committing resources to expensive downstream experiments.
Surface which compounds warrant early laboratory time and which need further evidence first.
Complement medicinal chemistry and toxicology workflows with transparent computational evidence.
Generate structured computational toxicity outputs for client programs.
Use transparent research-grade predictions for experimental prioritization.
Your candidate molecular library.
Endpoint-specific screening runs.
Calibrated toxicity calls.
Uncertainty, domain, novelty and OOD.
Structured testing priority.
Laboratory confirmation on prioritized compounds.
Discuss a research pilot using your candidate compounds. Pricing is not published at this stage.